Clinical Trials Directory

Trials / Completed

CompletedNCT01036646

User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity

Status
Completed
Phase
Study type
Observational
Enrollment
183 (actual)
Sponsor
Abbott RDx Cardiometabolic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This multi-center study is designed to evaluate the ability of intended lay users (patients on oral anticoagulation therapy, OAT, or their caregivers) to 1) operate the INRatio Prothrombin Time (PT) Monitoring System utilizing the INRatio test strip newly designed for low sample volume and heparin insensitivity, and 2) obtain accurate results for the quantitative determination of International Normalized Ratio (INR) when self-testing using fingerstick capillary blood. Patients will be trained by their healthcare provider using the instructions for use and product labeling provided. The accuracy of the patient INR results will be assessed by comparison to the INR results obtained by the site's trained healthcare professional using the same INRatio system (from a separate fingerstick collected from the same patient at the point-of-care), and with the INR results obtained on venous plasma obtained from the same patient and analyzed at a central laboratory with the Sysmex CA-560 System INR reference method.

Conditions

Timeline

Start date
2009-08-01
Primary completion
2010-06-01
Completion
2010-09-01
First posted
2009-12-21
Last updated
2013-02-11

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01036646. Inclusion in this directory is not an endorsement.